Summary: Researchers have reversed structural brain abnormalities and improved autism-related behaviors in a validated mouse model of autism spectrum disorder (ASD). The team identified a pronounced defect in the axon initial segment (AIS)—the neuronal region that initiates electrical action potentials—and used a targeted chemogenetic approach to restore AIS structure and rescue social and repetitive-behavior deficits.
Using the established 15q duplication (15q dup) mouse model that mirrors a human autism-associated genetic change, the investigators focused on a specific long-range circuit from the medial prefrontal cortex (mPFC), a key area for social behavior, to the dorsal raphe nucleus (DRN). They found that AIS segments in these projection neurons were abnormally shortened, which reduced neuronal excitability and impaired circuit function. By selectively activating this pathway with a chemogenetic tool (DREADD), the researchers restored AIS length, normalized neuronal firing properties, and produced measurable improvements in sociability and reductions in compulsive repetitive behaviors.
Key Findings
- AIS structural defect: The axon initial segment, the site where action potentials are initiated, was significantly shortened in affected neurons within the mPFC→DRN circuit.
- Circuit-specific impairment: The observed AIS abnormalities and reduced excitability were specific to long-range projection neurons involved in social behavior, rather than being uniform across all cortical neurons.
- Genetic model used: Results were obtained in 15q dup mice, which carry duplications analogous to those linked to human ASD.
- Chemogenetic reversal (DREADD): Selective activation of the mPFC→DRN projection via DREADD restored AIS length and neuronal excitability.
- Behavioral rescue: Structural and physiological recovery coincided with improved social interaction and a marked drop in repetitive behaviors in treated mice.
- Therapeutic implication: The findings indicate that AIS alterations in this ASD model reflect reversible maladaptive plasticity, pointing toward circuit-targeted strategies as a promising therapeutic direction.
Source: Shimane University
Background
Autism spectrum disorder is an early-onset neurodevelopmental condition characterized by social communication challenges and repetitive behaviors. While genetic risk and atypical brain development are established contributors, effective treatments that target the core neural mechanisms remain limited. Identifying reversible cellular and circuit-level abnormalities is essential for developing new therapeutic approaches.
A multidisciplinary team led by Professor Masashi Fujitani and Assistant Professor Yoshinori Otani (Department of Anatomy and Neuroscience, Shimane University) with collaborators at Kobe University and Hyogo Medical University analyzed structural and functional properties of neurons in 15q dup mice. Their study, published in Cell Death & Disease (May 19, 2026), specifically examined AIS morphology and circuit function in the mPFC→DRN pathway and tested whether targeted activation could reverse the observed deficits.
The team demonstrated that shortened AIS length in projection neurons corresponded with diminished firing capacity and impaired plasticity. By applying a circuit-specific chemogenetic intervention to activate these neurons, they successfully normalized AIS structure and rescued autism-like behaviors in the mouse model. These results indicate that impaired AIS plasticity can be reversed, restoring both neuronal excitability and behavior.
Key Questions Answered:
A: The axon initial segment (AIS) is the region at the base of the axon where action potentials are generated. Its length and organization determine a neuron’s ability to initiate and propagate electrical signals. In this ASD model, a shortened AIS in specific social-circuit neurons reduces their firing capability, which can impair communication across brain regions involved in social behavior.
A: Researchers used DREADD, a chemogenetic tool that allows selective activation of a defined neuronal population. Activating the mPFC→DRN projection induced activity-dependent structural plasticity that lengthened the AIS back to normal ranges and restored neuronal excitability.
A: The study shows that core neuronal and behavioral abnormalities in this mouse model are not permanent but can be reversed by targeting specific circuits. That opens a new avenue for developing circuit-based interventions aimed at restoring neural excitability and alleviating behavioral symptoms in ASD.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The original journal paper was reviewed in full by the editorial team.
- Additional explanatory context was added by staff for clarity.
About this autism research news
Author: Shuko Imawaka
Source: Shimane University
Contact: Shuko Imawaka – Shimane University
Image: The image is credited to Neuroscience News
Original Research: Open access. “Restoration of axon initial segment plasticity via chemogenetic activation rescues autism-related behaviors” by Yoshinori Otani, Xiaowei Zhu, Xinlang Liu, Kohei Koga, Ryo Kawabata, Hisao Miyajima, Toru Takumi & Masashi Fujitani. Cell Death and Disease. DOI: 10.1038/s41419-026-08873-0
Abstract
Restoration of axon initial segment plasticity via chemogenetic activation rescues autism-related behaviors
Autism spectrum disorder presents a significant clinical challenge and requires identification of novel targets that address its root pathophysiology. The axon initial segment (AIS) is a central site for action potential initiation and homeostatic plasticity, yet its role in ASD has not been well defined.
This study reports structural and functional AIS deficits in a clinically relevant ASD mouse model carrying a 15q11-13 duplication. Pyramidal neurons in the medial prefrontal cortex displayed shortened AIS, reduced excitability, and impaired plasticity. These changes were particularly evident in long-range circuits such as the mPFC–dorsal raphe nucleus pathway, which contributes to social behavior.
A circuit-specific chemogenetic strategy that activates mPFC→DRN projection neurons normalized AIS structure and rescued core ASD-like behaviors, including social deficits and repetitive behaviors. These findings indicate that AIS alterations in this model represent reversible maladaptive plasticity rather than permanent neuropathology, and they highlight circuit-targeted AIS modulation as a promising therapeutic approach to correct neuronal excitability deficits in ASD.